KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universal Health Services (UHS) Depreciation & Amortization (CF): 2009-2017

Historic Depreciation & Amortization (CF) for Universal Health Services (UHS) over the last 9 years, with Q3 2017 value amounting to $110.2 million.

  • Universal Health Services' Depreciation & Amortization (CF) rose 627.22% to $110.2 million in Q3 2017 from the same period last year, while for Jun 2018 it was $110.2 million, marking a year-over-year decrease of 7466.61%. This contributed to the annual value of $559.6 million for FY2024, which is 448.1% up from last year.
  • Universal Health Services' Depreciation & Amortization (CF) amounted to $110.2 million in Q3 2017, which was up 627.22% from $113.1 million recorded in Q2 2017.
  • Over the past 5 years, Universal Health Services' Depreciation & Amortization (CF) peaked at $113.1 million during Q2 2017, and registered a low of $79.9 million during Q1 2013.
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $99.0 million (2015), whereas its average is $98.0 million.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first surged by 1681.12% in 2014, then skyrocketed by 427.12% in 2016.
  • Universal Health Services' Depreciation & Amortization (CF) (Quarter) stood at $88.7 million in 2013, then rose by 10.61% to $98.1 million in 2014, then increased by 4.9% to $102.9 million in 2015, then rose by 4.39% to $107.4 million in 2016, then grew by 2.59% to $110.2 million in 2017.
  • Its Depreciation & Amortization (CF) was $110.2 million in Q3 2017, compared to $113.1 million in Q2 2017 and $110.8 million in Q1 2017.